Insufficient scRNA-seq data for expression of OTC at single-cell level.
Insufficient scRNA-seq data for expression of OTC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3298.66 | 226 / 226 | 89% | 145.30 | 363 / 406 |
pancreas | 90% | 62.20 | 295 / 328 | 39% | 2.63 | 70 / 178 |
intestine | 76% | 255.33 | 730 / 966 | 49% | 5.92 | 260 / 527 |
stomach | 42% | 12.60 | 150 / 359 | 53% | 7.29 | 152 / 286 |
lung | 80% | 37.44 | 465 / 578 | 8% | 1.00 | 92 / 1155 |
uterus | 74% | 42.80 | 126 / 170 | 2% | 0.06 | 9 / 459 |
brain | 55% | 9.20 | 1464 / 2642 | 10% | 0.14 | 70 / 705 |
bladder | 48% | 12.38 | 10 / 21 | 15% | 1.60 | 78 / 504 |
thymus | 62% | 20.29 | 405 / 653 | 1% | 0.01 | 4 / 605 |
esophagus | 43% | 13.63 | 617 / 1445 | 20% | 2.27 | 36 / 183 |
adipose | 56% | 30.06 | 676 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 50% | 23.71 | 670 / 1335 | 0% | 0 | 0 / 0 |
breast | 46% | 16.66 | 211 / 459 | 1% | 0.01 | 8 / 1118 |
ovary | 31% | 11.46 | 56 / 180 | 11% | 0.42 | 47 / 430 |
heart | 30% | 8.24 | 262 / 861 | 0% | 0 | 0 / 0 |
prostate | 20% | 5.27 | 49 / 245 | 1% | 0.01 | 4 / 502 |
skin | 11% | 2.02 | 202 / 1809 | 1% | 0.01 | 5 / 472 |
peripheral blood | 12% | 6.25 | 113 / 929 | 0% | 0 | 0 / 0 |
spleen | 8% | 3.61 | 20 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 6% | 0.78 | 15 / 258 | 2% | 0.02 | 4 / 230 |
kidney | 2% | 0.38 | 2 / 89 | 4% | 0.19 | 35 / 901 |
muscle | 5% | 0.78 | 39 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006593 | Biological process | ornithine catabolic process |
GO_0007494 | Biological process | midgut development |
GO_0032868 | Biological process | response to insulin |
GO_0001889 | Biological process | liver development |
GO_0055081 | Biological process | monoatomic anion homeostasis |
GO_0097272 | Biological process | ammonium homeostasis |
GO_0070781 | Biological process | response to biotin |
GO_0000050 | Biological process | urea cycle |
GO_0010043 | Biological process | response to zinc ion |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0042450 | Biological process | arginine biosynthetic process via ornithine |
GO_0019240 | Biological process | citrulline biosynthetic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0004585 | Molecular function | ornithine carbamoyltransferase activity |
GO_0005543 | Molecular function | phospholipid binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0016597 | Molecular function | amino acid binding |
GO_0042301 | Molecular function | phosphate ion binding |
Gene name | OTC |
Protein name | ornithine carbamoyltransferase (EC 2.1.3.3) Ornithine transcarbamylase, mitochondrial (OTCase) (EC 2.1.3.3) (Ornithine carbamoyltransferase, mitochondrial) |
Synonyms | |
Description | FUNCTION: Catalyzes the second step of the urea cycle, the condensation of carbamoyl phosphate with L-ornithine to form L-citrulline . The urea cycle ensures the detoxification of ammonia by converting it to urea for excretion . . |
Accessions | ENST00000643344.1 ENST00000039007.5 P00480 A0A2R8Y829 |